{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:59:38Z","timestamp":1790812778000,"version":"4.1.0"},"reference-count":194,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Restrictive cardiomyopathies (RCMs) are a diverse group of myocardial diseases with a wide range of aetiologies, including familial, genetic and acquired diseases and ranging from very rare to relatively frequent cardiac disorders. In all these diseases, imaging techniques play a central role. Advanced imaging techniques provide important novel data on the diagnostic and prognostic assessment of RCMs. This EACVI consensus document provides comprehensive information for the appropriateness of all non-invasive imaging techniques for the diagnosis, prognostic evaluation, and management of patients with RCM.<\/jats:p>","DOI":"10.1093\/ehjci\/jex034","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T03:55:48Z","timestamp":1487130948000},"page":"1090-1121","source":"Crossref","is-referenced-by-count":120,"title":["Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the \u201cWorking Group on myocardial and pericardial diseases\u201d of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography"],"prefix":"10.1093","volume":"18","author":[{"given":"Gilbert","family":"Habib","sequence":"first","affiliation":[{"name":"1Aix- Aix-Marseille Univ, URMITE, Aix Marseille Universit\u00e9\u2014UM63, CNRS 7278, IRD 198, INSERM 1095"},{"name":"2Cardiology Department, APHM, La Timone Hospital, Boulevard Jean Moulin, 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bucciarelli-Ducci","sequence":"additional","affiliation":[{"name":"3Bristol Heart Institute, National Institute of Health Research (NIHR) Bristol Cardiovascular Biomedical Research Unit (BRU), University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida L P","family":"Caforio","sequence":"additional","affiliation":[{"name":"4Cardiology, Department of Cardiological Thoracic and Vascular Sciences, University of Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Cardim","sequence":"additional","affiliation":[{"name":"5Multimodality Cardiac Imaging Department, Sports Cardiology and Cardiomyopathies Centre-Hospital da Luz; Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[{"name":"6Universit\u00e9 Versailles Saint Quentin, INSERM U1018, H\u00f4pital Ambroise Par\u00e9, Boulogne-Billancourt, France"},{"name":"7Centre de r\u00e9f\u00e9rence pour les maladies cardiaques h\u00e9r\u00e9ditaires, APHP, ICAN, H\u00f4pital de la Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cosyns","sequence":"additional","affiliation":[{"name":"8CHVZ (Centrum voor Hart en Vaatziekten\u2014UZ Brussel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Dehaene","sequence":"additional","affiliation":[{"name":"9Department of Radiology and Cardiovascular Imaging, APHM, H\u00f4pitaux de la Timone, P\u00f4le d\u2019imagerie M\u00e9dicale, 13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Derumeaux","sequence":"additional","affiliation":[{"name":"10Department of Physiology, INSERM U955, Universit\u00e9 Paris-Est Creteil, Henri Mondor Hospital, DHU-ATVB, AP-HP, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Donal","sequence":"additional","affiliation":[{"name":"11Cardiologie\u2014CHU Rennes & CIC-IT 1414 & LTSI INSERM 1099 \u2013 Universit\u00e9 Rennes-1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R","family":"Dweck","sequence":"additional","affiliation":[{"name":"12Centre for Cardiovascular Science, University of Edinburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Edvardsen","sequence":"additional","affiliation":[{"name":"13Department of Cardiology, Center for Cardiological Innovation and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway"},{"name":"14University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Anna","family":"Erba","sequence":"additional","affiliation":[{"name":"15Regional Center of Nuclear Medicine, Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ernande","sequence":"additional","affiliation":[{"name":"10Department of Physiology, INSERM U955, Universit\u00e9 Paris-Est Creteil, Henri Mondor Hospital, DHU-ATVB, AP-HP, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[{"name":"16University Heart Center Zurich, Interventional Cardiology and Cardiac Imaging 19, Zurich"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Galderisi","sequence":"additional","affiliation":[{"name":"17Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Grapsa","sequence":"additional","affiliation":[{"name":"18Department of Cardiovascular Sciences, Imperial College of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Jacquier","sequence":"additional","affiliation":[{"name":"19Department of Radiology and Cardiovascular Imaging, APHM, H\u00f4pitaux de la Timone, P\u00f4le d\u2019imagerie M\u00e9dicale, Aix-Marseille Universit\u00e9, CNRS, CRMBM UMR 7339, 13385 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[{"name":"20Department of Molecular Pathology, Institute for Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[{"name":"21Departments of Cardiology, Heart Valve Clinic, University of Li\u00e8ge Hospital, GIGA Cardiovascular Sciences, CHU Sart Tilman, Li\u00e8ge, Belgium"},{"name":"22Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Neglia","sequence":"additional","affiliation":[{"name":"23Cardiovascular Department, Fondazione Toscana G. Monasterio, CNR Institute of Clinical Physiology, Scuola Superiore Sant'Anna, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pepe","sequence":"additional","affiliation":[{"name":"24Magnetic Resonance Imaging Unit, Fondazione G. Monasterio C.N.R.\u2014Regione Toscana Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone-Filardi","sequence":"additional","affiliation":[{"name":"17Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen E","family":"Petersen","sequence":"additional","affiliation":[{"name":"25Department of Advanced Cardiovascular Imaging, William Harvey Research Institute, National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Plein","sequence":"additional","affiliation":[{"name":"26Division of Biomedical Imaging, Multidisciplinary Cardiovascular Research Centre, Leeds Institute of Cardiovascular and Metabolic Medicine LIGHT Laboratories, University of Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A","family":"Popescu","sequence":"additional","affiliation":[{"name":"27University of Medicine and Pharmacy \u2018Carol Davila\u2019\u2014Euroecolab, Institute of Cardiovascular Diseases, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Reant","sequence":"additional","affiliation":[{"name":"28CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Elif","family":"Sade","sequence":"additional","affiliation":[{"name":"29Baskent University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Salaun","sequence":"additional","affiliation":[{"name":"30Cardiology Department, La Timone Hospital, Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riemer H J A","family":"Slart","sequence":"additional","affiliation":[{"name":"31Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, The Netherlands"},{"name":"32Department of Biomedical Photonic Imaging, University of Twente, PO Box 217, 7500 AEEnschede, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tribouilloy","sequence":"additional","affiliation":[{"name":"33Department of Cardiology, University Hospital Amiens, Amiens, France and INSERM U-1088, Jules Verne University of Picardie, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Zamorano","sequence":"additional","affiliation":[{"name":"34University Hospital Ramon y Cajal Carretera de Colmenar Km 9,100, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EACVI Scientific Documents Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[{"name":"34University Hospital Ramon y Cajal Carretera de Colmenar Km 9,100, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Haugaa","sequence":"additional","affiliation":[{"name":"34University Hospital Ramon y Cajal Carretera de Colmenar Km 9,100, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Indian Academy of Echocardiography","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Vijayaraghavan","sequence":"additional","affiliation":[{"name":"34University Hospital Ramon y Cajal Carretera de Colmenar Km 9,100, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"2026080919292821600_jex034-B1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and federation of cardiology task force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B3","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ejechocard\/jep156","article-title":"Restritive cardiomyopathies","volume":"10","author":"Nihoyannopoulos","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026080919292821600_jex034-B5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive cardiomyopathy","volume":"336","author":"Kushwaha","year":"1997","journal-title":"N Engl J Med"},{"key":"2026080919292821600_jex034-B6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00001573-200209000-00005","article-title":"Echocardiographic assessment of patients with hypertrophic and restrictive cardiomyopathy: imaging and echocardiography","volume":"17","author":"Tam","year":"2002","journal-title":"Curr Opin Cardiol"},{"key":"2026080919292821600_jex034-B7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/heart.86.3.343","article-title":"Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis","volume":"86","author":"Hancock","year":"2001","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.CIR.83.3.808","article-title":"Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study","volume":"83","author":"Klein","year":"1991","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/hrt.2003.027763","article-title":"Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation","volume":"90","author":"Hyodo","year":"2004","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9149(83)80139-8","article-title":"Myocardial texture characterization by two-dimensional echocardiography","volume":"51","author":"Bhandari","year":"1983","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B12","doi-asserted-by":"crossref","DOI":"10.1111\/echo.13278","article-title":"Longitudinal strain of left ventricular basal segments and E\/e\u2019 ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study","author":"Schiano-Lomoriello","year":"2016","journal-title":"Echocardiography"},{"key":"2026080919292821600_jex034-B13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcmg.2007.10.006","article-title":"Disparate patterns of left ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy","volume":"1","author":"Sengupta","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1532-429X-15-91","article-title":"Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update","volume":"15","author":"Kramer","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919292821600_jex034-B15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10976640009148691","article-title":"Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance","volume":"2","author":"Bellenger","year":"2000","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919292821600_jex034-B16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ehjci\/jeu128","article-title":"European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease","volume":"16","author":"Cosyns","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00330-005-0009-0","article-title":"Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy","volume":"16","author":"Francone","year":"2006","journal-title":"Eur Radiol"},{"key":"2026080919292821600_jex034-B18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/JAHA.115.002613","article-title":"Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage","volume":"4","author":"Schelbert","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2026080919292821600_jex034-B21","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919292821600_jex034-B23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12968-016-0259-9","article-title":"Comparison of 3 T and 1.5 T for T2* magnetic resonance of tissue iron","volume":"18","author":"Alam","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919292821600_jex034-B26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jcmg.2010.04.009","article-title":"Multimodality imaging of pericardial diseases","volume":"3","author":"Yared","year":"2010","journal-title":"JACC Cardiovascular imaging"},{"key":"2026080919292821600_jex034-B27","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ejrad.2014.05.035","article-title":"Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: multidetector computed tomography versus magnetic resonance imaging","volume":"83","author":"Zhao","year":"2014","journal-title":"European journal of radiology"},{"key":"2026080919292821600_jex034-B28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcmg.2010.08.020","article-title":"Myocardial viability by dual-energy delayed enhancement computed tomography","volume":"4","author":"Hamilton-Craig","year":"2011","journal-title":"JACC Cardiovascular imaging"},{"key":"2026080919292821600_jex034-B29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1148\/radiol.13121889","article-title":"Measurement of tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced mr imaging","volume":"268","author":"Bandula","year":"2013","journal-title":"Radiology"},{"key":"2026080919292821600_jex034-B30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(77)91102-3","article-title":"Scanning for soft-tissue amyloid","volume":"1","author":"Kula","year":"1977","journal-title":"Lancet"},{"key":"2026080919292821600_jex034-B31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques","volume":"21","author":"Aljaroudi","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2026080919292821600_jex034-B32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"21","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"key":"2026080919292821600_jex034-B33","doi-asserted-by":"crossref","first-page":"W256","DOI":"10.2214\/AJR.12.8737","article-title":"Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy","volume":"200","author":"Minutoli","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"2026080919292821600_jex034-B34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","article-title":"Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy","volume":"6","author":"Coutinho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B35","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1136\/hrt.2011.226076","article-title":"Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment","volume":"97","author":"Youssef","year":"2011","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080919292821600_jex034-B37","article-title":"Clinical Utility of Combined FDG-PET\/MR to Assess Myocardial Disease","author":"Apgral","journal-title":"JACC Cardiovasc Imaging 2016 Jun 29"},{"key":"2026080919292821600_jex034-B38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/HCO.0b013e32832a1d2e","article-title":"Restrictive cardiomyopathy","volume":"24","author":"Mogensen","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"2026080919292821600_jex034-B39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0735-1097(98)00026-6","article-title":"Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits","volume":"31","author":"Arbustini","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292821600_jex034-B40","first-page":"236","article-title":"Cardiac ultrastructure in primary restrictive cardiomyopathy","volume":"84","author":"Arbustini","year":"1983","journal-title":"Chest"},{"key":"2026080919292821600_jex034-B41","doi-asserted-by":"crossref","first-page":"W121","DOI":"10.1097\/RTI.0b013e3181ced17a","article-title":"Hypertrophic cardiomyopathy with restrictive phenotype and myocardial crypts","volume":"25","author":"Cannavale","year":"2010","journal-title":"J Thorac Imaging"},{"key":"2026080919292821600_jex034-B42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: the great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"2026080919292821600_jex034-B43","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1253\/circj.CJ-14-1425","article-title":"Echocardiographic assessment of the cardiac amyloidoses","volume":"79","author":"Koyama","year":"2015","journal-title":"Circ J"},{"key":"2026080919292821600_jex034-B45","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B46","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2459\/01.JCM.0000247321.49912.23","article-title":"Detection of increased left ventricular filling pressure by pulsed tissue Doppler in cardiac amyloidosis","volume":"7","author":"Innelli","year":"2006","journal-title":"J Cardiovasc Med"},{"key":"2026080919292821600_jex034-B47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"22","author":"Tendler","year":"2015","journal-title":"Amyloid"},{"key":"2026080919292821600_jex034-B48","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B49","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/echo.13278","article-title":"Longitudinal strain of left ventricular basal segments and E\/e\u2019 ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study","volume":"33","author":"Schiano-Lomoriello","year":"2016","journal-title":"Echocardiography"},{"key":"2026080919292821600_jex034-B50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.echo.2010.03.027","article-title":"Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study","volume":"23","author":"Bellavia","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919292821600_jex034-B51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B52","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left Ventricular structure and function in TTR-related versus AL cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292821600_jex034-B55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B56","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"2026080919292821600_jex034-B57","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","article-title":"The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease","volume":"15","author":"Di Bella","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B59","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B60","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292821600_jex034-B61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B62","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B63","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","article-title":"Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association","volume":"16","author":"Cardim","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B64","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/heart.89.7.762","article-title":"Left ventricular remodelling, and systolic and diastolic function in young adults with beta thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data","volume":"89","author":"Bosi","year":"2003","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B65","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJM197911223012103","article-title":"Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload","volume":"301","author":"Leon","year":"1979","journal-title":"N Engl J Med"},{"key":"2026080919292821600_jex034-B66","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.109.913863","article-title":"Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives","volume":"3","author":"Kremastinos","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026080919292821600_jex034-B67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2459\/JCM.0b013e3282f20847","article-title":"Guideline recommendations for heart complications in thalassemia major","volume":"9","author":"Cogliandro","year":"2008","journal-title":"J Cardiovasc Med"},{"key":"2026080919292821600_jex034-B68","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1253\/circj.70.1037","article-title":"Survival in thalassaemia major patients","volume":"70","author":"Efthimiadis","year":"2006","journal-title":"Circ J"},{"key":"2026080919292821600_jex034-B69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-7120-5-24","article-title":"Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance imaging in transfusion dependent thalassemia major","volume":"5","author":"Giakoumis","year":"2007","journal-title":"Cardiovasc Ultrasound"},{"key":"2026080919292821600_jex034-B70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3324\/haematol.2009.019042","article-title":"Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging","volume":"96","author":"Pepe","year":"2011","journal-title":"Haematologica"},{"key":"2026080919292821600_jex034-B72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ehjci\/jeu191","article-title":"Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy","volume":"16","author":"Meloni","year":"2015","journal-title":"European Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B73","doi-asserted-by":"crossref","first-page":"e003230","DOI":"10.1161\/CIRCIMAGING.115.003230","article-title":"Multiparametric cardiac magnetic resonance survey in children with thalassemia major a multicenter study","volume":"8","author":"Casale","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B74","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/hrt.2008.156497","article-title":"Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major","volume":"95","author":"Pepe","year":"2009","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B75","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"2026080919292821600_jex034-B76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"2026080919292821600_jex034-B77","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.amjcard.2010.07.016","article-title":"When should cardiologists suspect Anderson-Fabry disease?","volume":"106","author":"Gambarin","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B78","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.2008080870","article-title":"Agalsidase alpha and kidney dysfunction in Fabry disease","volume":"20","author":"West","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2026080919292821600_jex034-B79","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00059-002-2429-9","article-title":"Fabry disease: focus on cardiac manifestations and molecular mechanisms","volume":"27","author":"Perrot","year":"2002","journal-title":"Herz"},{"key":"2026080919292821600_jex034-B80","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.114.009789","article-title":"Anderson-Fabry disease and other lysosomal storage disorders","volume":"130","author":"Nagueh","year":"2014","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2009.08.002","article-title":"Cardiac challenges in patients with Fabry disease","volume":"141","author":"Weidemann","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026080919292821600_jex034-B82","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2005.08.023","article-title":"Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy","volume":"111","author":"Hoign\u00e9","year":"2006","journal-title":"Int J Cardiol"},{"key":"2026080919292821600_jex034-B83","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000168482","article-title":"Agalsidase alpha slows the decline in renal function in patients with Fabry disease","volume":"29","author":"Feriozzi","year":"2009","journal-title":"Am J Nephrol"},{"key":"2026080919292821600_jex034-B84","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.hco.0000131534.25034.43","article-title":"Tissue Doppler imaging in Fabry disease","volume":"19","author":"Pieroni","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"2026080919292821600_jex034-B85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2008.04.075","article-title":"Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy","volume":"132","author":"Toro","year":"2009","journal-title":"Int J Cardiol"},{"key":"2026080919292821600_jex034-B86","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ejechocard\/jer109","article-title":"Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease","volume":"12","author":"Zamorano","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"2026080919292821600_jex034-B87","doi-asserted-by":"crossref","first-page":"W97","DOI":"10.2214\/AJR.08.1201","article-title":"Delayed-enhanced cardiac MRI for differentiation of Fabry\u2019s disease from symmetric hypertrophic cardiomyopathy","volume":"192","author":"De Cobelli","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"2026080919292821600_jex034-B88","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet Med"},{"key":"2026080919292821600_jex034-B89","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"key":"2026080919292821600_jex034-B90","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: clinical features, evaluation, and management","volume":"7","author":"D\u2019souza","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026080919292821600_jex034-B91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/oxfordjournals.eurheartj.a061369","article-title":"Echocardiographic features in the cardiac type of glycogen storage disease II","volume":"4","author":"Gussenhoven","year":"1983","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B92","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9149(76)90433-1","article-title":"Echocardiographic evidence of outflow tract obstruction in Pompe\u2019s disease (glycogen storage disease of the heart)","volume":"37","author":"Rees","year":"1976","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B93","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ymgme.2010.07.011","article-title":"Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy","volume":"101","author":"Barker","year":"2010","journal-title":"Mol Genet Metab"},{"key":"2026080919292821600_jex034-B94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000336448","article-title":"Cardiac magnetic resonance imaging in Danon disease","volume":"121","author":"Nucifora","year":"2012","journal-title":"Cardiology"},{"key":"2026080919292821600_jex034-B95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11845-013-0939-5","article-title":"A study of glycogen storage disease with 99Tcm-MIBI gated myocardial perfusion imaging","volume":"182","author":"Wei","year":"2013","journal-title":"Ir J Med Sci"},{"key":"2026080919292821600_jex034-B96","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/echo.12759","article-title":"Left ventricular diastolic dysfunction in type I Gaucher Disease: An Echo Doppler Study","volume":"32","author":"Lo Iudice","year":"2015","journal-title":"Echocardiography"},{"key":"2026080919292821600_jex034-B97","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/heartjnl-2015-309258","article-title":"Cardiac issues in adults with mucopolysaccharidoses; current knowledge and emerging needs","volume":"102","author":"Braunlin","year":"2016","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B98","first-page":"268","article-title":"Pseudoxanthoma elasticum with cardiac involvement. A case report and review of the literature","volume":"59","author":"Przybojewski","year":"1981","journal-title":"S Afr Med J"},{"key":"2026080919292821600_jex034-B99","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/ATVBAHA.113.301901","article-title":"Characterization of cardiovascular involvement in pseudoxanthoma elasticum families","volume":"33","author":"Campens","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026080919292821600_jex034-B100","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.amjcard.2005.11.091","article-title":"Left ventricular systolic and diastolic function by echocardiogram in pseudoxanthoma elasticum","volume":"97","author":"Nguyen","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B101","first-page":"785","article-title":"Pseudoxanthoma elasticum: case report with arterial stiffness evaluated by a research cardiovascular profiling system","volume":"20","author":"Sab\u00e1n-Ruiz","year":"2010","journal-title":"Eur J Dermatol"},{"key":"2026080919292821600_jex034-B102","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B103","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080919292821600_jex034-B104","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026080919292821600_jex034-B105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0929-6441(09)60031-X","article-title":"Echocardiographic Manifestations in Patients with Cardiac Sarcoidosis,","volume":"10","author":"Chiu","year":"2002","journal-title":"J Med Ultrasound"},{"key":"2026080919292821600_jex034-B106","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mje.2001.110785","article-title":"Transesophageal echocardiographic abnormalities in a case of cardiac sarcoidosis","volume":"14","author":"Hourigan","year":"2001","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919292821600_jex034-B107","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B108","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2009.11.011","article-title":"ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"55","author":"Hundley","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292821600_jex034-B109","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/hrt.2004.058016","article-title":"Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance","volume":"92","author":"Schulz-Menger","year":"2006","journal-title":"Heart"},{"key":"2026080919292821600_jex034-B110","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike","volume":"55","author":"Seward","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292821600_jex034-B111","first-page":"634","article-title":"Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death","volume":"16","author":"Lancefield","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B112","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"2026080919292821600_jex034-B113","first-page":"66","article-title":"Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET","volume":"55","author":"Keijsers","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2026080919292821600_jex034-B114","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"2026080919292821600_jex034-B116","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000001063","article-title":"Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"41","author":"Tang","year":"2016","journal-title":"Clin Nucl Med"},{"key":"2026080919292821600_jex034-B117","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11886-013-0370-6","article-title":"18)F-FDG PET\/CT for the assessment of myocardial sarcoidosis","volume":"15","author":"Skali","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"2026080919292821600_jex034-B118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoid","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292821600_jex034-B119","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","article-title":"Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis","volume":"195","author":"Yokoyama","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080919292821600_jex034-B120","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13) N-NH(3)\/[18F]FDG PE","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med"},{"key":"2026080919292821600_jex034-B121","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2026080919292821600_jex034-B122","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080919292821600_jex034-B123","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.phrs.2011.01.011","article-title":"The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis","volume":"63","author":"Leask","year":"2011","journal-title":"Pharmacol Res"},{"key":"2026080919292821600_jex034-B124","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026080919292821600_jex034-B125","first-page":"656","article-title":"A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)","volume":"17","author":"Follansbee","year":"1990","journal-title":"J Rheumatol"},{"key":"2026080919292821600_jex034-B126","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/art.23463","article-title":"Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients","volume":"58","author":"Meune","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026080919292821600_jex034-B127","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026080919292821600_jex034-B128","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.euje.2005.01.002","article-title":"Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by Doppler myocardial and strain rate imaging","volume":"6","author":"D\u2019Andrea","year":"2005","journal-title":"Eur J Echocardiogr"},{"key":"2026080919292821600_jex034-B129","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/art.30614","article-title":"Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis","volume":"63","author":"Yiu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2026080919292821600_jex034-B130","doi-asserted-by":"crossref","first-page":"e0126707","DOI":"10.1371\/journal.pone.0126707","article-title":"Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy","volume":"10","author":"Mueller","year":"2015","journal-title":"PLoS One"},{"key":"2026080919292821600_jex034-B131","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/ard.2008.095836","article-title":"Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients","volume":"68","author":"Hachulla","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026080919292821600_jex034-B132","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehr481","article-title":"Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology","volume":"33","author":"Ugander","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B133","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ehjci\/jeu167","article-title":"Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance","volume":"16","author":"Barison","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B134","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiol.13131280","article-title":"Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis","volume":"271","author":"Thuny","year":"2014","journal-title":"Radiology"},{"key":"2026080919292821600_jex034-B135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM198401193100302","article-title":"Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma","volume":"310","author":"Follansbee","year":"1984","journal-title":"N Engl J Med"},{"key":"2026080919292821600_jex034-B136","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B137","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCIMAGING.111.966796","article-title":"Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping","volume":"4","author":"Messroghli","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B138","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0360-3016(97)00467-7","article-title":"Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin\u2019s disease","volume":"39","author":"Constine","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026080919292821600_jex034-B139","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2005.01.029","article-title":"The incidence and functional consequences of RT-associated cardiac perfusion defects","volume":"63","author":"Marks","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026080919292821600_jex034-B140","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B141","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2459\/JCM.0000000000000165","article-title":"How to recognize endomyocardial fibrosis?","volume":"16","author":"Dato","year":"2015","journal-title":"J Cardiovasc Med"},{"key":"2026080919292821600_jex034-B142","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5339\/gcsp.2012.11","article-title":"Endomyocardial fibrosis: A form of endemic restrictive cardiomyopathy","volume":"2012","author":"Mocumbi","year":"2012","journal-title":"Glob Cardiol Sci Pract"},{"key":"2026080919292821600_jex034-B143","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pntd.0000097","article-title":"Endomyocardial fibrosis: still a mystery after 60 years","volume":"2","author":"Bukhman","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"2026080919292821600_jex034-B144","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10554-010-9753-6","article-title":"Echocardiography accurately assesses the pathological abnormalities of chronic endomyocardial fibrosis","volume":"27","author":"Mocumbi","year":"2011","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa0708629","article-title":"A population study of endomyocardial fibrosis in a rural area of Mozambique","volume":"359","author":"Mocumbi","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919292821600_jex034-B146","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jsha.2014.11.002","article-title":"Cardiac MRI findings of endomyocardial fibrosis (Loeffler\u2019s endocarditis) in a patient with rheumatoid arthritis","volume":"27","author":"Kharabish","year":"2015","journal-title":"J Saudi Heart Assoc"},{"key":"2026080919292821600_jex034-B147","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/rheumatology\/ket328","article-title":"Endomyocardial fibrosis in patients with confirmed Churg_Strauss syndrome","volume":"53","author":"Schneeweis","year":"2014","journal-title":"Rheumatology"},{"key":"2026080919292821600_jex034-B148","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/echo.13244","article-title":"A challenging differential diagnosis: distinguishing between endomyocardial fibrosis and apical hypertrophic cardiomyopathy","volume":"33","author":"Maia","year":"2016","journal-title":"Echocardiography"},{"key":"2026080919292821600_jex034-B149","first-page":"e115","article-title":"Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance","volume":"111","author":"Cury","year":"2005","journal-title":"Imaging Circulation"},{"key":"2026080919292821600_jex034-B150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCIMAGING.110.950675","article-title":"Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients","volume":"4","author":"Salemi","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B151","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ehjci\/jet198","article-title":"Non-tropical endomyocardial fibrosis associated with sarcoidosis","volume":"15","author":"Roper","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B152","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.acvd.2015.01.006","article-title":"Eosinophilic cardiac disease: molecular, clinical and imaging aspects","volume":"108","author":"Seguela","year":"2015","journal-title":"Arch Cardiovass Dis"},{"key":"2026080919292821600_jex034-B153","first-page":"1233","article-title":"Eosinophilic myocarditis: case series and review of literature","volume":"22","author":"Al Ali","year":"2006","journal-title":"Can J Cardiol"},{"key":"2026080919292821600_jex034-B154","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0002-9149(00)00841-9","article-title":"Clinical and echocardiographic features of hypereosinophilic syndromes","volume":"1","author":"Ommen","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ehjci\/jeu196","article-title":"Cardiac involvement in hypereosinophilic syndrome: role of multimodality imaging","volume":"16","author":"Simonnet","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B156","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.CIR.67.6.1219","article-title":"Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study","volume":"67","author":"Acquatella","year":"1983","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B157","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1080\/10428190400002293","article-title":"Rapid reversion of Loeffler\u2019s endocarditis by imatinib in early stage clonal hypereosinophilic syndrome","volume":"45","author":"Rotoli","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"2026080919292821600_jex034-B158","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1440-1673.2001.00972.x","article-title":"Idiopathic hypereosinophilic syndrome: magnetic resonance imaging findings in endomyocardial fibrosis","volume":"45","author":"Puvaneswary","year":"2001","journal-title":"Australas Radiol"},{"key":"2026080919292821600_jex034-B159","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.amjcard.2013.02.064","article-title":"Diagnosing cardiac involvement in the hypereosinophilic syndrome by cardiac magnetic resonance","volume":"112","author":"Porto","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B160","first-page":"e11","article-title":"Hypereosinophilic syndrome with cardiac involvement: early diagnosis by cardiac magnetic resonance imaging","volume":"515","author":"Pillar","year":"2012","journal-title":"Can J Cardiol"},{"key":"2026080919292821600_jex034-B161","first-page":"240","article-title":"Cardiac involvement in hypereosinophilic syndrome","volume":"69","author":"ten Oever","year":"2011","journal-title":"Neth J Med"},{"key":"2026080919292821600_jex034-B162","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.echo.2011.02.009","article-title":"Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease","volume":"24","author":"Haugaa","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919292821600_jex034-B163","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1572-0241.2004.40507.x","article-title":"Carcinoid tumors and fibrosis: an association with no explanation","volume":"99","author":"Modlin","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2026080919292821600_jex034-B164","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11886-006-0019-9","article-title":"Carcinoid heart disease","volume":"8","author":"Connolly","year":"2006","journal-title":"Curr Cardiol Rep"},{"key":"2026080919292821600_jex034-B165","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B166","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.CIR.102.10.1158","article-title":"Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function","volume":"102","author":"Urheim","year":"2000","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B167","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000431076","article-title":"Myocardial function by two-dimensional speckle tracking echocardiography and activin A may predict mortality in patients with carcinoid intestinal disease","volume":"132","author":"Zahid","year":"2015","journal-title":"Cardiology"},{"key":"2026080919292821600_jex034-B168","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/AC.67.2.2154218","article-title":"Carcinoid heart disease: typical findings on echocardiography and cardiac magnetic resonance","volume":"67","author":"Moerman","year":"2012","journal-title":"Acta Cardiol"},{"key":"2026080919292821600_jex034-B169","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1096\/fj.02-1122fje","article-title":"Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-ht2b receptor signaling","volume":"17","author":"Nebigil","year":"2003","journal-title":"FASEB J"},{"key":"2026080919292821600_jex034-B170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pharmthera.2011.03.008","article-title":"Serotonin receptors and heart valve disease\u2013it was meant 2b","volume":"132","author":"Hutcheson","year":"2011","journal-title":"Pharmacol Ther"},{"key":"2026080919292821600_jex034-B171","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.etp.2009.08.009","article-title":"Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans","volume":"62","author":"Fielden","year":"2010","journal-title":"Exp Toxicol Pathol"},{"key":"2026080919292821600_jex034-B172","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199804303381816","article-title":"Endocardial fibrosis associated with fenfluramine-phentermine","volume":"338","author":"Fowles","year":"1998","journal-title":"N Engl J Med"},{"key":"2026080919292821600_jex034-B173","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcha.2015.09.003","article-title":"Sub obstruction of left outflow tract secondary to benfluorex-induced endocardial fibrosis","volume":"9","author":"Szymanski","year":"2015","journal-title":"IJC Heart Vasculature"},{"key":"2026080919292821600_jex034-B174","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0002-8703(91)90587-8","article-title":"Constrictive pericarditis versus restrictive cardiomyopathy: a reappraisal and update of diagnostic criteria","volume":"122","author":"Vaitkus","year":"1991","journal-title":"Am Heart J"},{"key":"2026080919292821600_jex034-B175","first-page":"123","article-title":"Pathophysiology and differential diagnosis of restrictive cardiomyopathy","volume":"19","author":"Shabetai","year":"1988","journal-title":"Cardiovasc Clin"},{"key":"2026080919292821600_jex034-B176","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCIMAGING.112.000078","article-title":"Biventricular mechanics in constrictive pericarditis comparison with restrictive cardiomyopathy and impact of pericardiectomy","volume":"6","author":"Kusunose","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B177","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCIMAGING.113.001613","article-title":"Echocardiographic diagnosis of constrictive pericarditis. Mayo clinic criteria","volume":"7","author":"Welch","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B178","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.amjcard.2004.04.026","article-title":"Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography","volume":"94","author":"Ha","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B179","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1067\/mje.2002.127452","article-title":"Diagnostic value of mitral annular velocity for constrictive pericarditis in the absence of respiratory variation in mitral inflow velocity","volume":"15","author":"Ha","year":"2002","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919292821600_jex034-B180","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.amjcard.2003.12.029","article-title":"Accuracy and pitfalls of early diastolic motion of the mitral annulus for diagnosing constrictive pericarditis by tissue Doppler imaging","volume":"93","author":"Sengupta","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B181","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0002-9149(00)01278-9","article-title":"Comparison of new Doppler echocardiographic methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy","volume":"87","author":"Rajagopalan","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B182","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCIMAGING.114.002103","article-title":"Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy","volume":"7","author":"Amaki","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B183","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B184","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/01.CIR.0000087606.18453.FD","article-title":"Constrictive pericarditis in 26 patients with histologically normal pericardial thickness","volume":"108","author":"Talreja","year":"2003","journal-title":"Circulation"},{"key":"2026080919292821600_jex034-B185","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jcmg.2010.04.009","article-title":"Multimodality imaging of pericardial diseases","volume":"3","author":"Yared","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292821600_jex034-B186","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B187","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2010.03.020","article-title":"Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"106","author":"Olivotto","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B188","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.07.057","article-title":"Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy","volume":"104","author":"Biagini","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B189","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919292821600_jex034-B190","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2006.05.013","article-title":"Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)","volume":"98","author":"Nistri","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B191","first-page":"1339","article-title":"Implications of left ventricular remodeling in hypertrophic cardiomyopathy","volume":"81","author":"Maron","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026080919292821600_jex034-B192","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026080919292821600_jex034-B193","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/eurjhf\/hfq225","article-title":"Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry","volume":"13","author":"Habib","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080919292821600_jex034-B194","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/eurheartj\/ehi765","article-title":"Isolated ventricular non-compaction with restrictive cardiomyopathy","volume":"27","author":"Rapezzi","year":"2006","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/18\/10\/1090\/70577888\/ehjcimaging_18_10_1090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/18\/10\/1090\/70577888\/ehjcimaging_18_10_1090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:30:07Z","timestamp":1786318207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/18\/10\/1090\/3828464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":194,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,5,16]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jex034","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,5,16]]}}}